VTVT 8-K 2026-06-29

vTv Therapeutics Inc. (VTVT) 8-K dated 2026-06-29 — accession 0001641489-26-000024. This URL is the filing, not the VTVT hub.

vTv Therapeutics Inc. (VTVT) is a biotechnology company listed on NASDAQ.

vTv Therapeutics Inc. filed a 8-K on 2026-06-29. Accession 0001641489-26-000024.

Cached items: 5.07. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VTVT revenue for 2026-06-30 was $36.8M. Net income was $11.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. VTVT currently screens at market cap $133.9M.

Not investment advice. The VTVT SEC hub lists recent forms. The stock page is the research view.